Triple

T4210350
Position Surface form Disambiguated ID Type / Status
Subject Clinical and Translational Science Awards Program E93885 entity
Predicate abbreviation P43 FINISHED
Object CTSA Program E93885 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CTSA Program | Statement: [Clinical and Translational Science Awards Program, abbreviation, CTSA Program]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: CTSA Program
Context triple: [Clinical and Translational Science Awards Program, abbreviation, CTSA Program]
  • A. Clinical and Translational Science Awards Program chosen
    The Clinical and Translational Science Awards Program is a U.S. national consortium that supports academic medical institutions in accelerating the translation of scientific discoveries into improved patient care and public health.
  • B. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • C. Center for Scientific Review
    The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
  • D. Office of Translational Sciences
    The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
  • E. NCI-Designated Cancer Centers Program
    The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69b3451743608190808f41d17ccf2650 completed March 12, 2026, 10:58 p.m.
NER Named-entity recognition batch_69b34810de648190b09c5e705cf0a74e completed March 12, 2026, 11:11 p.m.
NED1 Entity disambiguation (via context triple) batch_69b5962ec4f8819085bef81ce71aa132 completed March 14, 2026, 5:09 p.m.
Created at: March 12, 2026, 11:03 p.m.